140 related articles for article (PubMed ID: 29301793)
1.
Shin H; Cha HJ; Na K; Lee MJ; Cho JY; Kim CY; Kim EK; Kang CM; Kim H; Paik YK
Cancer Res; 2018 Mar; 78(5):1214-1224. PubMed ID: 29301793
[TBL] [Abstract][Full Text] [Related]
2. The clinicopathological significance and relationship of Gli1, MDM2 and p53 expression in resectable pancreatic cancer.
Sheng W; Dong M; Zhou J; Li X; Liu Q; Dong Q; Li F
Histopathology; 2014 Mar; 64(4):523-35. PubMed ID: 24289472
[TBL] [Abstract][Full Text] [Related]
3. Induction of tumor apoptosis through a circular RNA enhancing Foxo3 activity.
Du WW; Fang L; Yang W; Wu N; Awan FM; Yang Z; Yang BB
Cell Death Differ; 2017 Feb; 24(2):357-370. PubMed ID: 27886165
[TBL] [Abstract][Full Text] [Related]
4. [Expression and clinical significance of P53 pathway-associated proteins in pancreatic carcinoma].
Yu GZ; Zhu MH; Chen Y; Ni CR; Li FM
Ai Zheng; 2005 Nov; 24(11):1398-403. PubMed ID: 16552971
[TBL] [Abstract][Full Text] [Related]
5. A novel apoptotic mechanism of genetically engineered adenovirus-mediated tumour-specific p53 overexpression through E1A-dependent p21 and MDM2 suppression.
Yamasaki Y; Tazawa H; Hashimoto Y; Kojima T; Kuroda S; Yano S; Yoshida R; Uno F; Mizuguchi H; Ohtsuru A; Urata Y; Kagawa S; Fujiwara T
Eur J Cancer; 2012 Sep; 48(14):2282-91. PubMed ID: 22244827
[TBL] [Abstract][Full Text] [Related]
6. PIM1 destabilization activates a p53-dependent response to ribosomal stress in cancer cells.
Sagar V; Caldarola S; Aria V; Monteleone V; Fuoco C; Gargioli C; Cannata S; Loreni F
Oncotarget; 2016 Apr; 7(17):23837-49. PubMed ID: 26993775
[TBL] [Abstract][Full Text] [Related]
7. Differential targeting of the cyclin-dependent kinase inhibitor, p21CIP1/WAF1, by chelators with anti-proliferative activity in a range of tumor cell-types.
Moussa RS; Kovacevic Z; Richardson DR
Oncotarget; 2015 Oct; 6(30):29694-711. PubMed ID: 26335183
[TBL] [Abstract][Full Text] [Related]
8. Mdm2 is required for inhibition of Cdk2 activity by p21, thereby contributing to p53-dependent cell cycle arrest.
Giono LE; Manfredi JJ
Mol Cell Biol; 2007 Jun; 27(11):4166-78. PubMed ID: 17371838
[TBL] [Abstract][Full Text] [Related]
9. Modification of p53 with O-linked N-acetylglucosamine regulates p53 activity and stability.
Yang WH; Kim JE; Nam HW; Ju JW; Kim HS; Kim YS; Cho JW
Nat Cell Biol; 2006 Oct; 8(10):1074-83. PubMed ID: 16964247
[TBL] [Abstract][Full Text] [Related]
10. Circulating microRNA-194 regulates human melanoma cells via PI3K/AKT/FoxO3a and p53/p21 signaling pathway.
Bai M; Zhang M; Long F; Yu N; Zeng A; Zhao R
Oncol Rep; 2017 May; 37(5):2702-2710. PubMed ID: 28358423
[TBL] [Abstract][Full Text] [Related]
11. [Expression of proteins in p53 (p14ARF-mdm2-p53-p21WAF/CIP1) pathway and their significance in exocrine pancreatic carcinoma].
Yu GZ; Zhu MH; Ni CR; Li FM; Zheng JM; Gong ZJ
Zhonghua Bing Li Xue Za Zhi; 2004 Apr; 33(2):130-4. PubMed ID: 15132849
[TBL] [Abstract][Full Text] [Related]
12. TAp73 alpha increases p53 tumor suppressor activity in thyroid cancer cells via the inhibition of Mdm2-mediated degradation.
Malaguarnera R; Vella V; Pandini G; Sanfilippo M; Pezzino V; Vigneri R; Frasca F
Mol Cancer Res; 2008 Jan; 6(1):64-77. PubMed ID: 18234963
[TBL] [Abstract][Full Text] [Related]
13. Angiogenic factor AGGF1 acts as a tumor suppressor by modulating p53 post-transcriptional modifications and stability via MDM2.
Si W; Zhou B; Xie W; Li H; Li K; Li S; Deng W; Shi P; Yuan C; Ke T; Ren X; Tu X; Zeng X; Weigelt B; Rubin BP; Chen Q; Xu C; Wang QK
Cancer Lett; 2021 Jan; 497():28-40. PubMed ID: 33069768
[TBL] [Abstract][Full Text] [Related]
14. Regulation of p53 and suppression of apoptosis by the soluble guanylyl cyclase/cGMP pathway in human ovarian cancer cells.
Fraser M; Chan SL; Chan SS; Fiscus RR; Tsang BK
Oncogene; 2006 Apr; 25(15):2203-12. PubMed ID: 16288207
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of the p53-MDM2 interaction by adenovirus delivery of ribosomal protein L23 stabilizes p53 and induces cell cycle arrest and apoptosis in gastric cancer.
Zhang Y; Shi Y; Li X; Du W; Luo G; Gou Y; Wang X; Guo X; Liu J; Ding J; Wu K; Fan D
J Gene Med; 2010 Feb; 12(2):147-56. PubMed ID: 20020415
[TBL] [Abstract][Full Text] [Related]
16. MiR-629 promotes human pancreatic cancer progression by targeting FOXO3.
Yan H; Li Q; Wu J; Hu W; Jiang J; Shi L; Yang X; Zhu D; Ji M; Wu C
Cell Death Dis; 2017 Oct; 8(10):e3154. PubMed ID: 29072689
[TBL] [Abstract][Full Text] [Related]
17. Normal human mammary epithelial cells proliferate rapidly in the presence of elevated levels of the tumor suppressors p53 and p21(WAF1/CIP1).
Huschtscha LI; Moore JD; Noble JR; Campbell HG; Royds JA; Braithwaite AW; Reddel RR
J Cell Sci; 2009 Aug; 122(Pt 16):2989-95. PubMed ID: 19638413
[TBL] [Abstract][Full Text] [Related]
18. Mdm2, p53, p21 and pAKT protein pathways in benign neoplasms of the salivary gland.
Marques YM; de Lima Mde D; de Melo Alves Sde M; Soares FA; de Araújo VC; Pinto Ddos S; Mantesso A
Oral Oncol; 2008 Sep; 44(9):903-8. PubMed ID: 18485798
[TBL] [Abstract][Full Text] [Related]
19. O-GlcNAc transferase regulates p21 protein levels and cell proliferation through the FoxM1-Skp2 axis in a p53-independent manner.
de Queiroz RM; Moon SH; Prives C
J Biol Chem; 2022 Sep; 298(9):102289. PubMed ID: 35868563
[TBL] [Abstract][Full Text] [Related]
20. Mdm2 inhibition of p53 induces E2F1 transactivation via p21.
Wunderlich M; Berberich SJ
Oncogene; 2002 Jun; 21(28):4414-21. PubMed ID: 12080472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
